• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    MannKind Corp. (MNKD)

    -NasdaqGM
    6.35 Up 0.07(1.11%) Jan 30, 4:00PM EST
    |After Hours : 6.35 0.00 (0.00%) Jan 30, 7:32PM EST
    Add to Portfolio
    Prev Close:6.28
    Open:6.27
    Bid:N/A
    Ask:8.23 x 200
    1y Target Est:9.36
    Beta:3.25
    Earnings Date:Feb 16 - Feb 20 (Est.)
    Day's Range:6.20 - 6.54
    52wk Range:3.80 - 11.48
    Volume:5,764,985
    Avg Vol (3m):4,318,750
    Market Cap:2.52B
    P/E (ttm):N/A
    EPS (ttm):-0.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MNKDUp 1.11%2.52B
    LLYDown 0.15%77.01B
    GSKDown 2.57%105.78B
    NVODown 2.96%116.48B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.48
    Quarterly EPS Est (Dec-14) :-0.09
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback